These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 33050459)

  • 1. May Mangafodipir or Other SOD Mimetics Contribute to Better Care in COVID-19 Patients?
    Karlsson JOG; Jynge P; Ignarro LJ
    Antioxidants (Basel); 2020 Oct; 9(10):. PubMed ID: 33050459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calmangafodipir [Ca4Mn(DPDP)5], mangafodipir (MnDPDP) and MnPLED with special reference to their SOD mimetic and therapeutic properties.
    Karlsson JO; Ignarro LJ; Lundström I; Jynge P; Almén T
    Drug Discov Today; 2015 Apr; 20(4):411-21. PubMed ID: 25463039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mangafodipir as a cardioprotective adjunct to reperfusion therapy: a feasibility study in patients with ST-segment elevation myocardial infarction.
    Karlsson JE; El-Saadi W; Ali M; Puskar W; Skogvard P; Engvall JE; Andersson RG; Maret E; Jynge P
    Eur Heart J Cardiovasc Pharmacother; 2015 Jan; 1(1):39-45. PubMed ID: 27533964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fodipir and its dephosphorylated derivative dipyridoxyl ethyldiamine are involved in mangafodipir-mediated cytoprotection against 7β-hydroxycholesterol-induced cell death.
    Laskar A; Andersson RG; Li W
    Pharmacology; 2013; 92(3-4):182-6. PubMed ID: 24080534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Manganese dipyridoxyl diphosphate: MRI contrast agent with antioxidative and cardioprotective properties?
    Brurok H; Ardenkjaer-Larsen JH; Hansson G; Skarra S; Berg K; Karlsson JO; Laursen I; Jynge P
    Biochem Biophys Res Commun; 1999 Jan; 254(3):768-72. PubMed ID: 9920816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mangafodipir trisodium injection, a new contrast medium for magnetic resonance imaging: detection and quantitation of the parent compound MnDPDP and metabolites in human plasma by high performance liquid chromatography.
    Toft KG; Friisk GA; Skotland T
    J Pharm Biomed Anal; 1997 Apr; 15(7):973-81. PubMed ID: 9160264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary vasoconstriction during regional nitric oxide inhalation: evidence of a blood-borne regulator of nitric oxide synthase activity.
    Hambraeus-Jonzon K; Chen L; Fredén F; Wiklund P; Hedenstierna G
    Anesthesiology; 2001 Jul; 95(1):102-12. PubMed ID: 11465547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Superior therapeutic index of calmangafodipir in comparison to mangafodipir as a chemotherapy adjunct.
    Karlsson JO; Kurz T; Flechsig S; Näsström J; Andersson RG
    Transl Oncol; 2012 Dec; 5(6):492-502. PubMed ID: 23323161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of inhaled nitric oxide following lung transplantation.
    Yerebakan C; Ugurlucan M; Bayraktar S; Bethea BT; Conte JV
    J Card Surg; 2009; 24(3):269-74. PubMed ID: 19438780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence that fodipir (DPDP) binds neurotoxic Pt
    Stehr JE; Lundström I; Karlsson JOG
    Sci Rep; 2019 Nov; 9(1):15813. PubMed ID: 31676855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insights on SARS-CoV-2 Molecular Interactions With the Renin-Angiotensin System.
    Costa LB; Perez LG; Palmeira VA; Macedo E Cordeiro T; Ribeiro VT; Lanza K; Simões E Silva AC
    Front Cell Dev Biol; 2020; 8():559841. PubMed ID: 33042994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2 infection in the lungs of human ACE2 transgenic mice causes severe inflammation, immune cell infiltration, and compromised respiratory function.
    Winkler ES; Bailey AL; Kafai NM; Nair S; McCune BT; Yu J; Fox JM; Chen RE; Earnest JT; Keeler SP; Ritter JH; Kang LI; Dort S; Robichaud A; Head R; Holtzman MJ; Diamond MS
    bioRxiv; 2020 Jul; ():. PubMed ID: 32676600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidation of nitric oxide by oxomanganese-salen complexes: a new mechanism for cellular protection by superoxide dismutase/catalase mimetics.
    Sharpe MA; Ollosson R; Stewart VC; Clark JB
    Biochem J; 2002 Aug; 366(Pt 1):97-107. PubMed ID: 11994046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First clinical experience with the magnetic resonance imaging contrast agent and superoxide dismutase mimetic mangafodipir as an adjunct in cancer chemotherapy-a translational study.
    Karlsson JO; Adolfsson K; Thelin B; Jynge P; Andersson RG; Falkmer UG
    Transl Oncol; 2012 Feb; 5(1):32-8. PubMed ID: 22348174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mangafodipir trisodium injection, a new contrast medium for magnetic resonance imaging: in vitro metabolism and protein binding studies of the active component MnDPDP in human blood.
    Toft KG; Kindberg GM; Skotland T
    J Pharm Biomed Anal; 1997 Apr; 15(7):983-8. PubMed ID: 9160265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitric oxide for inhalation in ST-elevation myocardial infarction (NOMI): a multicentre, double-blind, randomized controlled trial.
    Janssens SP; Bogaert J; Zalewski J; Toth A; Adriaenssens T; Belmans A; Bennett J; Claus P; Desmet W; Dubois C; Goetschalckx K; Sinnaeve P; Vandenberghe K; Vermeersch P; Lux A; Szelid Z; Durak M; Lech P; Zmudka K; Pokreisz P; Vranckx P; Merkely B; Bloch KD; Van de Werf F;
    Eur Heart J; 2018 Aug; 39(29):2717-2725. PubMed ID: 29800130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Proposed Approach to Pulmonary Long COVID: A Viewpoint.
    Gerayeli FV; Eddy R; Sin DD
    Eur Respir J; 2024 Mar; ():. PubMed ID: 38453258
    [No Abstract]   [Full Text] [Related]  

  • 18. Nitric oxide's physiologic effects and potential as a therapeutic agent against COVID-19.
    Ricciardolo FLM; Bertolini F; Carriero V; Högman M
    J Breath Res; 2020 Dec; 15(1):014001. PubMed ID: 33080582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pragmatic randomized controlled trial reports lack of efficacy of hydroxychloroquine on coronavirus disease 2019 viral kinetics.
    Lyngbakken MN; Berdal JE; Eskesen A; Kvale D; Olsen IC; Rueegg CS; Rangberg A; Jonassen CM; Omland T; Røsjø H; Dalgard O
    Nat Commun; 2020 Oct; 11(1):5284. PubMed ID: 33082342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A parallel-group, multicenter randomized, double-blinded, placebo-controlled, phase 2/3, clinical trial to test the efficacy of pyridostigmine bromide at low doses to reduce mortality or invasive mechanical ventilation in adults with severe SARS-CoV-2 infection: the Pyridostigmine In Severe COvid-19 (PISCO) trial protocol.
    Fragoso-Saavedra S; Iruegas-Nunez DA; Quintero-Villegas A; García-González HB; Nuñez I; Carbajal-Morelos SL; Audelo-Cruz BM; Arias-Martínez S; Caro-Vega Y; Calva JJ; Luqueño-Martínez V; González-Duarte A; Crabtree-Ramírez B; Crispín JC; Sierra-Madero J; Belaunzarán-Zamudio PF; Valdés-Ferrer SI
    BMC Infect Dis; 2020 Oct; 20(1):765. PubMed ID: 33066761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.